Phase II Study of Mitoguazone, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone for Patients with Diffuse Histologic Subtypes of Non-Hodgkin's Lymphoma: An Eastern Cooperative Oncology Group Study (PE481)
- 1 January 1998
- journal article
- clinical trial
- Published by Informa UK Limited in Leukemia & Lymphoma
- Vol. 30 (5-6), 601-607
- https://doi.org/10.3109/10428199809057572
Abstract
Mitoguazone, an investigational agent with significant activity in advanced lymphoma, was added to a modified CHOP regimen (COPA) in an effort to improve the activity of standard therapy in 66 previously untreated patients with stages II-IV lymphoma and diffuse histology of intermediate or high grade other than lymphoblastic in this phase II pilot study. The regimen was well tolerated and the complete response rate in diffuse large cell lymphoma was 55%. Sixty-five percent of all complete responders were in complete response for at least one year. Despite these excellent results, it is unlikely that the addition of mitoguazone improved results compared with those obtained with standard therapy alone, since similar results have been frequently reported with the latter.Keywords
This publication has 11 references indexed in Scilit:
- CHOP vs. ProMACE‐CytaBOM in the treatment of aggressive non‐Hodgkin's lymphomas: long‐term results of a multicenter randomized trialEuropean Journal of Haematology, 1996
- A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National Lymphoma Investigation reportBritish Journal of Cancer, 1996
- Phase III Comparative Trial Uisng CHOP vs CIOP in the Treatment of Advanced Intermediate-Grade Non-Hodgkin's LymphomaLeukemia & Lymphoma, 1995
- Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group.Journal of Clinical Oncology, 1994
- Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Comparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's LymphomaNew England Journal of Medicine, 1992
- A randomized comparison of methotrexate dose and the addition of bleomycin to chop therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas cancer and leukemia group B study 7851Cancer, 1990
- Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1987
- Effectiveness of methyl-GAG (methylglyoxal-bis[guanylhydrazone]) in patients with advanced malignant lymphomaBlood, 1981
- Complex formation with DNA and inhibition of nucleic acid synthesis by methylglyoxal bis(guanylhydrazone)Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1965